Evidence map›Paper›PMID 39741340›Full record

ReviewJournal of medical case reports2024

Disseminated Mycobacterium abscessus infection with idiopathic CD4+ T-lymphocytopenia: a case report and review of the literature.

Xianglin Wu, Mingzhu Zhai, Aohong Xu, Yi Zheng

Abstract readCase ReportsReview
In one paragraph

Review in Journal of medical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Frontiers in immunology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xianglin WuDepartment of Laboratory Medicine, Guangming District People's Hospital, Shenzhen, 518106, China.
Mingzhu ZhaiCenter for Medical Experiments (CME), Guangming District People's Hospital, Shenzhen, 518106, China.
Aohong XuCenter for Medical Experiments (CME), Guangming District People's Hospital, Shenzhen, 518106, China.
Yi ZhengCenter for Medical Experiments (CME), Guangming District People's Hospital, Shenzhen, 518106, China. zhengyi1205@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIdiopathic CD4+ T lymphocytopenia is a rare immune dysfunction disease that is usually found after opportunistic infections. Mycobacterium abscessus is a rapidly growing mycobacterium that can cause pulmonary infections, lymphadenitis, skin and soft tissue infections, disseminated infections, among others, as a conditional pathogenic bacterium. CASE PRESENTATION: We present the case of a 43-year-old Chinese woman who developed disseminated Mycobacterium abscessus infection due to idiopathic CD4+ T lymphocytopenia. The patient exhibited symptoms including skin infections, lymphadenitis, and bacteremia. A tailored multidrug therapy was initiated, guided by drug susceptibility testing. Within a month of treatment, the patient's fever resolved, and she exhibited a significant recovery and was discharged.

conclusionsCases of clinical idiopathic CD4+ T lymphocytopenia with Mycobacterium abscessus infection are not common. Clinicians should be vigilant and accurately identify Mycobacterium abscessus as an opportunistic pathogen when dealing with immunocompromised patients, in particular with idiopathic CD4+ T lymphocytopenia.

Indexed as

Anti-Bacterial AgentsMycobacterium abscessusMycobacterium Infections, NontuberculousT-Lymphocytopenia, Idiopathic CD4-PositiveAdultFemaleHumansImmunocompromised HostOpportunistic InfectionsTreatment OutcomeAnti-Bacterial AgentsAntimicrobial susceptibility testBloodstream infectionClinical characteristicsIdiopathic CD4+ T-lymphocytopenia (ICL)Mycobacterium abscessus

Identifiers

PMID39741340
PMCPMC11687038

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.